Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca opens new manufacturing facilty to support continued growth in Russia
-
AstraZeneca receives Complete Response Letter from US FDA for saxagliptin / dapagliflozin fixed-dose-combination
-
New England Journal of Medicine publishes results of head-to-head studies of brodalumab versus ustekinumab in psoriasis
-
AstraZeneca presents advances in oncology research at ECC 2015 with data on AZD9291, durvalumab and LYNPARZA™ (olaparib)
-
AstraZeneca to present data demonstrating diversity of its portfolio of innovative formulations and devices at the European Respiratory Society International Congress 2015
-
AstraZeneca supports crowd sourcing challenge to find new combination therapies for cancer
-
AstraZeneca presents positive pooled analysis demonstrating the effect of dapagliflozin on albuminuria in hypertensive patients with type 2 diabetes
-
AstraZeneca announces new tolerability, long-term efficacy and real-world adherence data for exenatide once weekly in patients with type 2 diabetes
-
AstraZeneca to present comprehensive data from its diabetes portfolio and pre-clinical research at EASD 2015
-
AstraZeneca purchases US biologics manufacturing facility to support growing pipeline
Latest articles and press releases
All of our latest press releases and articles are available to explore
